Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference13 articles.
1. Outpatient management of anticoagulation therapy;Breuil;Am Fam Physician,2007
2. Challenges of establishing new antithrombotic therapies in atrial fibrillation;Connolly;Circulation,2007
3. A replacement for warfarin: the search continues;Eikelboom;Circulation,2007
4. Factor Xa or thrombin: is factor Xa a better target?;Ansell;J Thromb Haemost,2007
Cited by 395 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study;Thrombosis Research;2024-02
2. Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients;Cancer;2024-01-30
3. Edoxaban eliminates hypercoagulability evoked by transient temperature changes in human whole blood;Journal of Arrhythmia;2023-11-06
4. Relationships, Current Issues, Safety and Efficacy of Oral Anticoagulation in Cancer Patients with Atrial Fibrillation;Journal of Clinical Medicine;2023-10-16
5. Update on laboratory practice for the diagnosis of lupus anticoagulant and the antiphospholipid syndrome;Exploration of Immunology;2023-10-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3